These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 469023)

  • 1. Pharmacokinetics of phenobarbital following single and repeated doses.
    Viswanathan CT; Booker HE; Welling PG
    J Clin Pharmacol; 1979; 19(5-6):282-9. PubMed ID: 469023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbital pharmacokinetics and bioavailability in adults.
    Nelson E; Powell JR; Conrad K; Likes K; Byers J; Baker S; Perrier D
    J Clin Pharmacol; 1982; 22(2-3):141-8. PubMed ID: 7068937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of oral and intramuscular phenobarbital.
    Viswanathan CT; Booker HE; Welling PG
    J Clin Pharmacol; 1978; 18(2-3):100-5. PubMed ID: 624773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenobarbital disposition in the neonate.
    Garrettson LK
    Addict Dis; 1975; 2(1-2):179-85. PubMed ID: 1163361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic fate of phenobarbital in man. N-Glucoside formation.
    Tang BK; Kalow W; Grey AA
    Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of the body clearance of phenobarbital by oral activated charcoal.
    Berg MJ; Berlinger WG; Goldberg MJ; Spector R; Johnson GF
    N Engl J Med; 1982 Sep; 307(11):642-4. PubMed ID: 7050705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study on the pharmacokinetics of phenobarbital in the neonatal foal.
    Spehar AM; Hill MR; Mayhew IG; Hendeles L
    Equine Vet J; 1984 Jul; 16(4):368-71. PubMed ID: 6479136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism and excretion of enzyme-inducing doses of phenobarbital by rats with bile fistulas.
    Levin SS; Vars HM; Schleyer H; Cooper DY
    Xenobiotica; 1986 Mar; 16(3):213-24. PubMed ID: 3705618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of phenobarbital glucosidation in the human neonate.
    Bhargava VO; Garrettson LK
    Dev Pharmacol Ther; 1988; 11(1):8-13. PubMed ID: 3383723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualizing phenobarbital dosing in neonates.
    Gilman ME; Toback JW; Gal P; Erkan NV
    Clin Pharm; 1983; 2(3):258-62. PubMed ID: 6883954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of phenobarbital in horses after single and repeated oral administration of the drug.
    Knox DA; Ravis WR; Pedersoli WM; Spano JS; Nostrandt AC; Krista LM; Schumacher J
    Am J Vet Res; 1992 May; 53(5):706-10. PubMed ID: 1524295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenobarbital--valporic acid interaction.
    Patel IH; Levy RH; Cutler RE
    Clin Pharmacol Ther; 1980 Apr; 27(4):515-21. PubMed ID: 6766833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.
    Nau H; Rating D; Häuser I; Jäger E; Koch S; Helge H
    Eur J Clin Pharmacol; 1980 Jul; 18(1):31-42. PubMed ID: 7398746
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
    Whyte MP; Dekaban AS
    Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with stable isotopes II: Phenobarbital pharmacokinetics during monotherapy.
    Browne TR; Evans JE; Szabo GK; Evans BA; Greenblatt DJ
    J Clin Pharmacol; 1985; 25(1):51-8. PubMed ID: 3973064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal.
    Pond SM; Olson KR; Osterloh JD; Tong TG
    JAMA; 1984 Jun; 251(23):3104-8. PubMed ID: 6726981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
    Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
    Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.